Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German bre...
Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers
About this item
Full title
Author / Creator
Sibert, Nora Tabea , Wesselmann, Simone , Breidenbach, Clara , Blohmer, Jens , Brückner, Barbara , Gebauer, Gerhard , dos Santos Guilherme, Marina , Hartkopf, Andreas , Lindner, Christoph , Peschel, Susanne , Rieger, Lorenz , Schad, Friedemann , Strecker, Paul , Ferencz, Julia , Dieng, Sebastian , Inwald, Elisabeth C. , Kowalski, Christoph and Ortmann, Olaf
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
Since 2008, guidelines recommend that patients with HER2-positive early breast cancer (BC) should receive adjuvant chemotherapy in combination with trastuzumab in Germany. However, recent studies highlight that a substantial share of patients do not receive trastuzumab. We investigate which patient characteristics are associated with a t...
Alternative Titles
Full title
Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers
Authors, Artists and Contributors
Author / Creator
Wesselmann, Simone
Breidenbach, Clara
Blohmer, Jens
Brückner, Barbara
Gebauer, Gerhard
dos Santos Guilherme, Marina
Hartkopf, Andreas
Lindner, Christoph
Peschel, Susanne
Rieger, Lorenz
Schad, Friedemann
Strecker, Paul
Ferencz, Julia
Dieng, Sebastian
Inwald, Elisabeth C.
Kowalski, Christoph
Ortmann, Olaf
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2519809215
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2519809215
Other Identifiers
ISSN
0171-5216
E-ISSN
1432-1335
DOI
10.1007/s00432-021-03651-1
